Jazz Pharmaceuticals Story Overview

JAZZ -- USA Stock  

USD 158.65  1.40  0.89%

Macroaxis does not monitor all media channels or aggregates social signals for Jazz Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Jazz Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Jazz Pharmaceuticals. Please also check Jazz Pharmaceuticals Hype Analysis, Jazz Pharmaceuticals Correlation and Jazz Pharmaceuticals Performance.
Acquisition by Paul Berns of 4500 shares of Jazz Pharmaceuticals subject to Rule 16b-3
Filed transaction by Jazz Pharmaceuticals Plc director. Grant, award or other acquisition pursuant to Rule 16b-3

Jazz Pharmaceuticals Public Limited Company insider trading alert for grant of nonstatutory stock option (right to buy) by Paul Berns, the corporate stakeholder, on January 3, 2018. This event was filed by Jazz Pharmaceuticals Plc with SEC on 2013-08-12. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on January 3, 2018 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 1.58% . The trading delta at closing time when the story was published against the current closing price is 12.60% .

Similar stores for Jazz Pharmaceuticals

Analysts See 2.95 EPS for Jazz Pharmaceuticals plcnews
The Cardinal Weekly Jazz Pharmaceuticals PLC Sentiment Improved, Because Thorold NewsFull coverage
few days ago at www.macroaxis.com 
Sale by Matthew Young of 700 shares of Jazz Pharmaceuticals
Macroaxis News
Filed transaction by Jazz Pharmaceuticals Plc officer. General open market or private sale of non-derivative or derivative security
over a week ago at http://cardinalweekly.com 
Are Analysts Bullish Jazz Pharmaceuticals plc After Last Week
news
The Cardinal Weekly Cadian Capital Management LP Has Lowered Position in Jazz Pharmaceuticals Plc by 83.68 Million MoneyMakingArticlesJazz Pharmaceuticals Plc Holder Rk Capital Management LLC Has Trimmed Its Position as Valuation Declined Thorold NewsFull coverage
over a week ago at http://cardinalweekly.com 
Senator Investment Group LP Has Upped Zayo Group Hldgs INC Holding by 36.54 Million as Market Value ...
news
The Cardinal Weekly As Zayo Group Hldgs INC Share Value Declined, Senator Investment Group LP Has Upped Its Position by ... Thorold NewsAs Zayo Group Hldgs INC Stock Declined, Senator Investment Group LP Has Upped Its Holding by 36.54 Million MoneyMakingArticlesFull coverage
over two weeks ago at http://cardinalweekly.com 
Institutional Investor Sentiment About Jazz Pharmaceuticals PLC Up
news
The Cardinal Weekly Full coverage
over three weeks ago at www.macroaxis.com 
Sale by Bruce Cozadd of 1300 shares of Jazz Pharmaceuticals
Macroaxis News
Filed transaction by Jazz Pharmaceuticals Plc director. General open market or private sale of non-derivative or derivative security
over a month ago at www.macroaxis.com 
Jazz Pharmaceuticals exotic insider transaction detected
Macroaxis News
Filed transaction by Jazz Pharmaceuticals Plc director. Unconventional Insider trading
over a month ago at www.macroaxis.com 
Sale by Michael Miller of 200 shares of Jazz Pharmaceuticals
Macroaxis News
Filed transaction by Jazz Pharmaceuticals Plc officer. General open market or private sale of non-derivative or derivative security
over a month ago at www.macroaxis.com 
Acquisition by Kenneth OKeefe of 38347 shares of Jazz Pharmaceuticals subject to Rule 16b-3
Macroaxis News
Filed transaction by Jazz Pharmaceuticals Plc director. Grant, award or other acquisition pursuant to Rule 16b-3
over a month ago at www.macroaxis.com 
Payment of 537 shares by Karen Wilson of Jazz Pharmaceuticals subject to Rule 16b-3
Macroaxis News
Filed transaction by Jazz Pharmaceuticals Plc officer. Payment of exercise price or tax liability by delivering or withholding securities
over a month ago at www.macroaxis.com 
Sale by Seamus Mulligan of 1699 shares of Jazz Pharmaceuticals
Macroaxis News
Filed transaction by Jazz Pharmaceuticals Plc director. General open market or private sale of non-derivative or derivative security
over three months ago at www.macroaxis.com 
Sale by Matthew Young of 700 shares of Jazz Pharmaceuticals
Macroaxis News
Filed transaction by Jazz Pharmaceuticals Plc officer. General open market or private sale of non-derivative or derivative security
over three months ago at http://santimes.com 
USANA Health Sciences, Inc. s director Myron Wentz Unloaded 44285 Shares of the Company Jazz ...
news
San TimesFactors of Influence in 2018, Key Indicators and Opportunity within The Andersons, Ferroglobe, Paylocity Holding ... GlobeNewswireFull coverage

Current Liabilities

Current Liabilities Comparative Analysis

  Current Liabilities 
      Jazz Pharmaceuticals Comparables 
Jazz Pharmaceuticals is currently under evaluation in current liabilities category among related companies. Current Liabilities is company's short term debts. This usually includes obligations that are due within next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Peers

Jazz Pharmaceuticals Related Equities

DVAX  9.59 %   
0%
100.0%
DNLI  1.94 %   
0%
20.0%
DOVA  1.39 %   
0%
14.0%
NK  0.77 %   
0%
8.0%
ECYT  0.13 %   
0%
1.0%
DRNA  0.57 %   
5.0%
0%
DMPI  1.75 %   
18.0%
0%
EQ  3.21 %   
33.0%
0%
CO  3.93 %   
40.0%
0%
EARS  6.93 %   
72.0%
0%
Please also check Jazz Pharmaceuticals Hype Analysis, Jazz Pharmaceuticals Correlation and Jazz Pharmaceuticals Performance. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Search macroaxis.com